Clinical trial
Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients
NCT04747275 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 18, 2021
- Completion date
- November 1, 2021
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypothyroidism, trisomy 21